Biological Nanoscaffolds from Hierarchical Construction to Applications

Area of Science:

• Biomaterials Science
• Nanotechnology
• Molecular Biology

Background:

• Artificial scaffolds are increasingly researched, with biological scaffolds showing unique benefits over synthetic organic and polymer options.
• Biological scaffolds utilize foundational biomolecules like nucleic acids (DNA/RNA) and proteins, offering advantages in nanoparticle assembly, protein integration, and drug delivery.
• Key advantages include precise spatial structures, genetic programmability, and excellent biocompatibility due to natural, degradable components.

Purpose of the Study:

• To review and classify bottom-up constructed biological scaffolds based on their constituent biomacromolecules (nucleic acids and proteins).
• To examine the framework structures and key features of these biological scaffolds.
• To discuss the diverse applications of artificial bioscaffolds in various fields.

Main Methods:

• Classification of biological scaffolds based on constituent biomacromolecules: nucleic acids and proteins.
• Analysis of framework structures and characteristic features of each scaffold class.
• Review of existing literature on the applications of artificial bioscaffolds.

Main Results:

• Biological scaffolds, categorized by DNA/RNA or protein composition, exhibit distinct structural and functional properties.
• The intrinsic properties and symmetry of biomacromolecules directly influence the characteristics of the assembled nanomaterials.
• These scaffolds demonstrate significant potential in nanoparticle assembly, protein engineering, and advanced drug delivery systems.

Conclusions:

• Biological scaffolds represent a promising class of nanomaterials with inherent precision and genetic programmability.
• Their biocompatibility and tunable properties make them ideal for advanced applications in medicine and nanotechnology.
• Further development of biological scaffolds is expected to drive innovation in biomaterials and nanomedicine.